<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Diabetes and Metabolic Disorders</JournalTitle><Volume>6</Volume><Issue>0</Issue></Journal><ArticleTitle>THE EFFECT OF L – CARNITINE ON SERUM NITRIC OXIDE LEVEL AND ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN STZ – INDUCED DIABETIC AND NORMAL RATS.</ArticleTitle><FirstPage>196</FirstPage><LastPage>196</LastPage><AuthorList><Author><FirstName>Ali mohammad</FirstName><LastName>Sharifi</LastName></Author><Author><FirstName>Maryam</FirstName><LastName>Ghaderpanahi</LastName></Author><Author><FirstName>Seyed Ziaedin</FirstName><LastName>Hosseini Mazhari</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>05</Day></PubDate></History><Abstract>Background: Cardiovascular disease including hypertension are complications of long-standing diabetes. A few Studies had shown the positive effects of L-carnitine on hypertension. In this study, the possible effects of L-carnitne on nitric oxide (NO) levels and angiotensin-converting enzyme (ACE) activity in serum as well as systolic blood pressure (SBP) in diabetic and normal rats were studied.
Methods: In this study forty rats were used in four groups including non-treated control (C), L-carnitne treated control (CT), diabetic (D) and L-carnitne treated diabetic (DT). Diabetes was induced in rats by injection of stereptozotosin. Both of C &amp;amp; D groups had a free access to food and water and CT &amp;amp; DT groups were received daily dose of L-carnation in drinking water. At the end of 12 weeks SBP, serum NO and ACE activity were measured.
Results: Systolic blood pressure was significantly decreased in DT group compared to D group. Serum ACE activity was also significantly decreased in DT group compared to D group and the serum NO levels were significantly increased in DT &amp;amp; CT groups compared to D &amp;amp; C groups respectively.
Conclusion: Finally it could be concluded that L-carnitine may reduce SBP in diabetic rats via elevation of serum NO levels and reduction of serum ACE activity.</Abstract><web_url>https://jdmd.tums.ac.ir/index.php/jdmd/article/view/196</web_url></Article></Articles>
